| Haplotype-resolved diverse human genomes and integrated analysis of structural variation P Ebert, PA Audano, Q Zhu, B Rodriguez-Martin, D Porubsky, MJ Bonder, ... Science 372 (6537), eabf7117, 2021 | 434 | 2021 |
| Alternative polyadenylation mediates genetic regulation of gene expression BE Mittleman, S Pott, S Warland, T Zeng, Z Mu, M Kaur, Y Gilad, Y Li ELife 9, e57492, 2020 | 57 | 2020 |
| The impact of cell type and context-dependent regulatory variants on human immune traits Z Mu, W Wei, B Fair, J Miao, P Zhu, YI Li Genome biology 22 (1), 122, 2021 | 42 | 2021 |
| Clinical and genome-wide analysis of serum platinum levels after cisplatin-based chemotherapy MR Trendowski, O El-Charif, MJ Ratain, P Monahan, Z Mu, HE Wheeler, ... Clinical Cancer Research 25 (19), 5913-5924, 2019 | 20 | 2019 |
| Alignment of single-cell RNA-seq samples without overcorrection using kernel density matching M Chen, Q Zhan, Z Mu, L Wang, Z Zheng, J Miao, P Zhu, YI Li Genome Research 31 (4), 698-712, 2021 | 7 | 2021 |
| A genetically engineered Escherichia coli that senses and degrades tetracycline antibiotic residue Z Mu, Z Zou, Y Yang, W Wang, Y Xu, J Huang, R Cai, Y Liu, Y Mo, B Wang, ... Synthetic and systems biotechnology 3 (3), 196-203, 2018 | 7 | 2018 |
| Epigenetic variation impacts individual differences in the transcriptional response to influenza infection KA Aracena, YL Lin, K Luo, A Pacis, S Gona, Z Mu, V Yotova, R Sindeaux, ... Nature Genetics, 1-12, 2024 | 6* | 2024 |
| Shaping immunity: The influence of natural selection on population immune diversity HE Randolph, KA Aracena, YL Lin, Z Mu, LB Barreiro Immunological Reviews, 2024 | 2 | 2024 |
| Dissecting the Genetic Basis of Human Immune-Related Diseases Z Mu The University of Chicago, 2024 | | 2024 |
| A splicing-based multi-tissue joint transcriptome-wide association study identifies susceptibility genes for breast cancer G Gao, J McClellan, AN Barbeira, PN Fiorica, JL Li, Z Mu, OI Olopade, ... medRxiv, 2023.10. 15.23297045, 2023 | | 2023 |
| Pharmacokinetic modeling of serum platinum reveals extent of long-term exposure and associated comorbidities after cisplatin treatment MR Trendowski, O El-Charif, Z Mu, MJ Ratain, H Wheeler, PC Dinh, ... Cancer Research 79 (13_Supplement), 3904-3904, 2019 | | 2019 |
| Pharmacokinetic (PK) modeling of serum platinum to reveal extent of long-term exposure and associated comorbidities after cisplatin treatment. O El Charif, Z Mu, ER Gamazon, PC Dinh, S Ardeshirrouhanifard, ... Journal of Clinical Oncology 36 (15_suppl), 10058-10058, 2018 | | 2018 |
Yang I LiUniversity of ChicagoVerified email at uchicago.edu
